Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599324 | 1.00 | CA2 (0.30) | CA2 | |
| SCHEMBL4598997 | 0.97 | — | — | |
| SCHEMBL4599047 | 0.92 | — | — | |
| SCHEMBL2945407 | 0.85 | — | — | |
| SCHEMBL4598920 | 0.82 | — | — | |
| SCHEMBL6607326 | 0.82 | CA2 (0.32) | CA2 | |
| SCHEMBL10490386 | 0.82 | CYP1A2 (0.33) | — | |
| SCHEMBL6055461 | 0.80 | CA2 (0.31) | CA2 | |
| SCHEMBL9647392 | 0.79 | — | — | |
| SCHEMBL21085042 | 0.74 | CHRM1 (0.36) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372854-B2 | Pyrrolo[2,3-D]pyrimidine compounds | PFIZER INC. (US) | 2013-02-12 | — | — | US | claimed |
| EP-2513114-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | Pfizer Inc. (US) | 2012-10-24 | — | — | EP | claimed |
| US-20110294826-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | PFIZER INC. (US) | 2011-12-01 | — | — | US | claimed |
| WO-2011075334-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | PFIZER INC. (US) | 2011-06-23 | — | — | WO | claimed |
| US-8372854-B2 | Pyrrolo[2,3-D]pyrimidine compounds | PFIZER INC. (US) | 2013-02-12 | — | — | US | disclosed |
| CN-101974120-B | Nano-crystalline silicon containing deep ultraviolet negative amplification type photoresist and film forming resin thereof | KUNSHAN XIDI ELECTRO OPTIC MATERIALS CO LTD | 2012-12-26 | — | — | CN | disclosed |
| EP-2513114-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | Pfizer Inc. (US) | 2012-10-24 | — | — | EP | disclosed |
| CN-101974119-B | Nano silicon containing deep ultraviolet positive photoresist and forming resin thereof | KUNSHAN XIDI ELECTRO OPTIC MATERIALS CO LTD | 2012-10-03 | — | — | CN | disclosed |
| CN-102050946-B | Ultraviolet positive photoresist containing nano silicon polyamide and film-forming resin thereof | KUNSHAN XIDI OPTOELECTRONIC MATERIAL CO LTD | 2012-06-27 | — | — | CN | disclosed |
| CN-101979435-B | Nanometer silicon-containing ultraviolet thick film positive photoresist and film forming resin thereof | KUNSHAN XIDI PHOTOELECTRIC MATERIAL CO LTD | 2012-05-30 | — | — | CN | disclosed |
| US-20110294826-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | PFIZER INC. (US) | 2011-12-01 | — | — | US | disclosed |
| WO-2011075334-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | PFIZER INC. (US) | 2011-06-23 | — | — | WO | disclosed |
| CN-102050946-A | Ultraviolet positive photoresist containing nano silicon polyamide and film-forming resin thereof | KUNSHAN XIDI OPTOELECTRONIC MATERIAL CO LTD | 2011-05-11 | — | — | CN | disclosed |
| CN-101979435-A | Nanometer silicon-containing ultraviolet thick film positive photoresist and film forming resin thereof | KUNSHAN XIDI PHOTOELECTRIC MATERIAL CO LTD | 2011-02-23 | — | — | CN | disclosed |
| CN-101974119-A | Nano silicon containing deep ultraviolet positive photoresist and forming resin thereof | KUNSHAN XIDI ELECTRO OPTIC MATERIALS CO LTD | 2011-02-16 | — | — | CN | disclosed |
| CN-101974120-A | Nano-crystalline silicon containing deep ultraviolet negative amplification type photoresist and film forming resin thereof | KUNSHAN XIDI ELECTRO OPTIC MATERIALS CO LTD | 2011-02-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294826-A1 | PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS | JAK3, JAK1, JAK2 | CA2 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.